Table 3. Bivariate analysis of the variables associated with grouping isolates.
| Variables | Grouping | p* | ||||
|---|---|---|---|---|---|---|
| Yes | No | |||||
| n | % | n | % | |||
| Sex | ||||||
| Male | 357 | 79.3 | 93 | 20.6 | ||
| Female | 234 | 80.4 | 57 | 19.6 | 0.397 | |
| Age | ||||||
| 0–15 years | 10 | 90.9 | 1 | 9.1 | 0.21 | |
| 16–30 years | 215 | 83 | 44 | 71 | 0.137 | |
| 31–45 years | 167 | 76.6 | 51 | 23.4 | 0.385 | |
| 46–60 years | 118 | 80.3 | 29 | 19.7 | 0.243 | |
| 61–75 years | 28 | 65.1 | 15 | 34.9 | 0.379 | |
| >76 years | 18 | 72 | 7 | 28 | ref | |
| Status of treatment | ||||||
| PT | 132 | 81.9 | 29 | 18.1 | ||
| NT | 459 | 79.1 | 121 | 20.8 | 0.24 | |
| Susceptibility to first-line drugs | ||||||
| R | 369 | 80.4 | 90 | 19.6 | ||
| S | 192 | 77.7 | 55 | 22.3 | ||
| ND | 30 | 85.7 | 5 | 14.3 | 0.229 | |
| MDR | ||||||
| Yes | 125 | 85 | 22 | 14.9 | ||
| No | 466 | 78.4 | 128 | 21.5 | 0.045 | |
| Period of the study | ||||||
| 1999–2005 | 323 | 78.8 | 87 | 21.2 | ||
| 2006–2012 | 268 | 77.7 | 63 | 19 | 0.26 | |
| Family | ||||||
| LAM | 280 | 93.3 | 20 | 6.7 | ref | |
| Beijing | 23 | 95.8 | 1 | 4.8 | 0.527 | |
| U | 45 | 95.7 | 2 | 4.3 | 0.51 | |
| S | 7 | 87.5 | 1 | 12.5 | 0.435 | |
| H | 125 | 87.4 | 18 | 12.6 | 0.031 | |
| X | 8 | 61.5 | 5 | 38.5 | 0.001 | |
| T | 54 | 72.9 | 20 | 27.1 | <0.001 | |
| Orphan | 45 | 35.7 | 81 | 64.3 | <0.001 | |
| MANU | 4 | 100 | 0 | 0 | NA | |
| M. bovis | 0 | 0 | 1 | 100 | NA | |
| CAS1_Delhi | 0 | 0 | 1 | 100 | NA | |
* Test of significance: Fisher’s Exact